Abbr. Expansion Instances Papers News
ARDS acute respiratory distress syndrome
The most intense severity of COVID-19 is not only acute respiratory distress syndrome (ARDS), it also causes multi-organ failure, the post-infection secondary effect as well as death.
65 65 0
VE vaccine effectiveness
During an outbreak in Shanghai’s SARS-CoV-2 infection-naïve population, we evaluated vaccine effectiveness (VE) against Omicron infection, severe or critical COVID-19, and COVID-19-related death.MethodsA matched case-control study was conducted among people aged ≥3 years between 2 December 2021 through 13 May 2022.
36 35 1
AEs adverse events
The overall prevalence of adverse events (AEs) was 61.2% and its occurrence was not associated with neuropathy type.
18 15 3
mRNA messenger RNA
Abstract Background We conducted a prospective cohort study at Kaiser Permanente Southern California to evaluate the relative vaccine effectiveness (rVE) of a booster dose vs 2-dose primary series of messenger RNA (mRNA)-1273 in immunocompetent individuals.
17 17 0
GMTs geometric mean titer
The geometric mean titer (GMT) of micro-virus neutralizing (micro-VNT) antibody against wild-type virus was 1,280, 11,762, 54,047, and 62,084, respectively.
11 10 1
VAERS Vaccine Adverse Event Reporting System
Can data analysis of vaccine adverse reactions responses provide etiology insights for high reactogenicity vaccines?/p /secsec titleMethods/title pThe Vaccine Adverse Event Reporting System (VAERS) database was data mined for all vaccine adverse events data by vaccine, age, gender, dose, and day of onset post vaccination.
10 10 0
AEFI adverse events following immunization
IntroductionAlthough the European Medicines Agency (EMA) encourage coronavirus disease 2019 (COVID-19) vaccination in pregnant women, the scientific evidence supporting the use of COVID-19 vaccines during pregnancy is still limited.AimWe aimed to investigate adverse events following immunization (AEFI) with COVID-19 vaccines during pregnancy.MethodsWe retrieved Individual Case Safety Reports (ICSRs) related to the use of COVID-19 vaccines during pregnancy from the EudraVigilance database for the year 2021.
7 7 0
aHRs adjusted hazard ratios
Cox proportional hazards models were used to estimate adjusted hazard ratios (aHRs) with 95% confidence intervals (CIs), comparing outcomes (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] infection and coronavirus disease 2019 [COVID-19] hospitalization and hospital death) in the booster-dose and 2-dose groups.
6 6 0
ROR reporting odds ratio
The reporting odds ratio (ROR) was computed to compare the reporting probability of spontaneous abortion between COVID-19 vaccines.ResultsDuring the study period, among 1,315,315 ICSRs related to COVID-19 vaccines, we retrieved 3,252 (0.25%) reports related to the use in pregnancy.
4 4 0
BBB blood-brain barrier
Objectives: This review aims to clear the polemics of COVID-19 vaccine-antidepressants interaction in these 3 aspects: (1) cytokines and cytochrome P450 pathway, (2) blood-brain barrier (BBB) involvement and (3) and its interaction with polyethylene glycol (PEG), the potential allergenic culprit following COVID-19 vaccination.
4 4 0